Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Depreciation & Amortization (CF) (2016 - 2026)

Gyre Therapeutics has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $656000.0 for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 42.3% to $656000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 60.17% year-over-year, with the annual reading at $2.5 million for FY2025, 60.17% up from the prior year.
  • Depreciation & Amortization (CF) was $656000.0 for Q4 2025 at Gyre Therapeutics, up from $649000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $867000.0 in Q4 2022 and troughed at $40000.0 in Q3 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $287000.0 (2023), against an average of $324050.0.
  • Year-over-year, Depreciation & Amortization (CF) soared 653.91% in 2022 and then crashed 65.63% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $115000.0 in 2021, then soared by 653.91% to $867000.0 in 2022, then crashed by 65.63% to $298000.0 in 2023, then surged by 54.7% to $461000.0 in 2024, then soared by 42.3% to $656000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Depreciation & Amortization (CF) are $656000.0 (Q4 2025), $649000.0 (Q3 2025), and $641000.0 (Q2 2025).